Fresh analysis indicates that individuals who stop using new weight-loss injections like Wegovy and Mounjaro can put back on lost weight much more quickly than those who halt traditional lifestyle programs.
Research printed in a prominent health publication points out that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month after stopping.
"People buying these treatments should be informed of the potential of fast rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb.
Such speed of recovery implies a return to original weight within about a year and a half.
Analyzing Approaches
The analysis, which looked at 37 of trials involving over 9,000 of participants, contrasted the results of these new drugs with older methods.
Scientists emphasize that individuals who lose weight through dieting usually experience a slower creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Rapid Regain
Experts propose the way of the jabs is key to understanding the heightened regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone concentrations far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement means appetite is no longer kept in check, making overeating much more probable."
An Ongoing Condition?
Health authorities recommend the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts contend that, due to the significant potential of weight regain, the therapy is often long-term.
This perspective is echoed by pharmaceutical companies, who note that the findings "emphasize the chronic nature of obesity," akin to managing conditions like hypertension.
User Testimonies
Individuals who have discontinued the jabs report a powerful return of hunger.
"It was like something that goes on and I was suddenly starving," said one woman.
This challenge is compounded if patients have not established permanent lifestyle or habit modifications during therapy.
Significant Interest
Recent estimates indicate that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Use is higher among women than males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts stress that while these medications are potent tools for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on integrated lifestyle support.